June 18 (Reuters) - Telix Pharmaceuticals Ltd TLX.AX :
* RECOMMENCEMENT OF ZIRCON PHASE III TRIAL RECRUITMENT IN EU
* ZIRCON PHASE III TRIAL OF TLX250-CDX RECOMMENCED PATIENT RECRUITMENT AFTER PAUSE TO DUE TO COVID-19
* EXPECTS CLINICAL TRIAL SITES IN AUSTRALIA, CANADA, TURKEY, USA TO BE REACTIVATED BETWEEN NOW AND SEPT